Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean Marc Pascussi

Showing results (11-20 of 77) with videos related to

Pageof 8
Sort By:
Orvosi Hetilap|June 27, 2008
[Crosstalk between cholesterol homeostasis and drug metabolism]Krisztina Kohalmy, Damjana Rozman, Jean-Marc Pascussi, et al.
Bulletin Du Cancer|August 7, 2016
[Not Available]Jean-Marc Pascussi, Julie Giraud, Emmanuelle Samalin, et al.
Molecular Endocrinology (Baltimore, Md.)|January 4, 2003
Transcriptional analysis of the orphan nuclear receptor constitutive androstane receptor (NR1I3) gene promoter: identification of a distal glucocorticoid response elementJean Marc Pascussi, Maryvonne Busson-Le Coniat, Patrick Maurel, et al.
Environmental Toxicology and Pharmacology|July 27, 2011
Zearalenone activates pregnane X receptor, constitutive androstane receptor and aryl hydrocarbon receptor and corresponding phase I target genes mRNA in primary cultures of human hepatocytesImen Ayed-Boussema, Jean Marc Pascussi, Patrick Maurel, et al.
International Journal of Toxicology|October 14, 2011
Effect of aflatoxin B1 on nuclear receptors PXR, CAR, and AhR and their target cytochromes P450 mRNA expression in primary cultures of human hepatocytesImen Ayed-Boussema, Jean-Marc Pascussi, Patrick Maurel, et al.
Current Drug Metabolism|April 14, 2006
Involvement of cytoskeleton in AhR-dependent CYP1A1 expressionZdenek Dvorák, Radim Vrzal, Jitka Ulrichová, et al.
European Journal of Cancer (Oxford, England : 1990)|March 3, 2006
Is nuclear factor kappa-B the missing link between inflammation, cancer and alteration in hepatic drug metabolism in patients with cancer?Eric Assenat, Sabine Gerbal-chaloin, Patrick Maurel, et al.
Pharmacogenetics and Genomics|August 27, 2011
The human primary hepatocyte transcriptome reveals novel insights into atorvastatin and rosuvastatin actionMateja Hafner, Peter Juvan, Tadeja Rezen, et al.
The Journal of Biological Chemistry|May 7, 2002
Expression of CYP3A4, CYP2B6, and CYP2C9 is regulated by the vitamin D receptor pathway in primary human hepatocytesLionel Drocourt, Jean-Claude Ourlin, Jean-Marc Pascussi, et al.
Drug and Chemical Toxicology|August 13, 2011
Ochratoxin A induces CYP3A4, 2B6, 3A5, 2C9, 1A1, and CYP1A2 gene expression in primary cultured human hepatocytes: a possible activation of nuclear receptorsImen Ayed-Boussema, Jean Marc Pascussi, Chiraz Zaied, et al.
Pageof 8

Showing results (11-20 of 77) with videos related to

Sort By:
Pageof 8
Orvosi Hetilap|June 27, 2008
[Crosstalk between cholesterol homeostasis and drug metabolism]Krisztina Kohalmy, Damjana Rozman, Jean-Marc Pascussi, et al.
Bulletin Du Cancer|August 7, 2016
[Not Available]Jean-Marc Pascussi, Julie Giraud, Emmanuelle Samalin, et al.
Molecular Endocrinology (Baltimore, Md.)|January 4, 2003
Transcriptional analysis of the orphan nuclear receptor constitutive androstane receptor (NR1I3) gene promoter: identification of a distal glucocorticoid response elementJean Marc Pascussi, Maryvonne Busson-Le Coniat, Patrick Maurel, et al.
Environmental Toxicology and Pharmacology|July 27, 2011
Zearalenone activates pregnane X receptor, constitutive androstane receptor and aryl hydrocarbon receptor and corresponding phase I target genes mRNA in primary cultures of human hepatocytesImen Ayed-Boussema, Jean Marc Pascussi, Patrick Maurel, et al.
International Journal of Toxicology|October 14, 2011
Effect of aflatoxin B1 on nuclear receptors PXR, CAR, and AhR and their target cytochromes P450 mRNA expression in primary cultures of human hepatocytesImen Ayed-Boussema, Jean-Marc Pascussi, Patrick Maurel, et al.
Current Drug Metabolism|April 14, 2006
Involvement of cytoskeleton in AhR-dependent CYP1A1 expressionZdenek Dvorák, Radim Vrzal, Jitka Ulrichová, et al.
European Journal of Cancer (Oxford, England : 1990)|March 3, 2006
Is nuclear factor kappa-B the missing link between inflammation, cancer and alteration in hepatic drug metabolism in patients with cancer?Eric Assenat, Sabine Gerbal-chaloin, Patrick Maurel, et al.
Pharmacogenetics and Genomics|August 27, 2011
The human primary hepatocyte transcriptome reveals novel insights into atorvastatin and rosuvastatin actionMateja Hafner, Peter Juvan, Tadeja Rezen, et al.
The Journal of Biological Chemistry|May 7, 2002
Expression of CYP3A4, CYP2B6, and CYP2C9 is regulated by the vitamin D receptor pathway in primary human hepatocytesLionel Drocourt, Jean-Claude Ourlin, Jean-Marc Pascussi, et al.
Drug and Chemical Toxicology|August 13, 2011
Ochratoxin A induces CYP3A4, 2B6, 3A5, 2C9, 1A1, and CYP1A2 gene expression in primary cultured human hepatocytes: a possible activation of nuclear receptorsImen Ayed-Boussema, Jean Marc Pascussi, Chiraz Zaied, et al.
Pageof 8